Singapore to Witness Significant Advancements in Pharmaceutical Contract Manufacturing

With cost-cutting measures on a roll by pharmaceutical firms, the global contract manufacturing sector is set to be worth US$ 27.5 Billion by the end of 2011, says RNCOS.

Noida, India (prHWY.com) February 29, 2012 - According to our new research report, "Global Contract Manufacturing Market Analysis", the worldwide contract manufacturing industry has consistently performed well in recent times. The total estimated industry size of the global pharmaceutical contact manufacturing stood at around US$ 27.5 Billion by the end of 2011. With the mounting pressure on pharmaceutical companies to cut down cost, the industry is further likely to perform exceptionally well in the coming years. Emerging countries will be the main focus-area.

The report has found that Singapore holds an important place for contract manufacturing in pharmaceutical industry landscape. The country possesses an effective industry infrastructure and IP structure compared to its neighboring Asian competitors. Factors including strong government initiatives and rising investments in infrastructure will further propel the contract manufacturing market in Singapore. Moreover, it is expected that the contract manufacturing of biologics and bio-similar will hold a major share in the overall contract manufacturing industry in future.

The report, "Global Contract Manufacturing Market Analysis", depicts the current picture of contract manufacturing market in key countries of the developed and developing world. It investigates the prevailing trends in the market and analyzes their impact on the future performance of the sector. Some of the key issues faced by the industry, such as political and economical impact, IP issues, and quality assurance risk, have also been covered to recognize the challenges and constraints.

The report covers all the key aspects of the global contract manufacturing market landscape and provides prudent analysis of the drivers, trends, and current developments. The analysis is an outcome of extensive research that leads to enrich clients with reliable statistics and proper information flow. The future projection in key areas of the report takes into account the effective techniques in order to provide a realistic outlook. Overall, the report is likely to provide potential clients with an esteemed view of the global contract manufacturing sector.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM265.htm

Some of our Related Reports are:

- Global Telemedicine Market Analysis (http://www.rncos.com/Report/IM331.htm)
- Personalized Medicine Market Analysis (http://www.rncos.com/Report/IM305.htm)
- Global Regenerative Medicine Market (http://www.rncos.com/Report/IM363.htm)
- Emerging Pharmaceutical Markets Globally
(http://www.rncos.com/Report/IM081.htm)
- Booming Clinical Trials Market in India (http://www.rncos.com/Report/IM564.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

About RNCOS

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behaviour. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.

###

Tag Words: pharma market

Categories: Health

Press Release Contact
B-129, Sector 6 Noida - 201301
91-120-4224-700
91-120-4224-707

Link To This Press Release:

URL HTML Code